HFA Premium Access

Patient management - From oral treatment to transplant

Event: Heart Failure 2018 & World Congress on Acute Heart Failure
Topic: Chronic Heart Failure
Session type: Rapid Fire Abstracts
Date: 28 May 2018
Time: 14:15 - 15:45

Session

15 presentations in this session

Structured follow-up program of patients with heart failure: impact on quality of life and prognosis.

Speaker: Doctor J. AGOSTINHO (Lisbon, PT)
Thumbnail

Impact of physicians' adherence to guideline-recommended therapy on heart failure re-hospitalizations: data from the Optimize Heart Failure Care Program

Speaker: Doctor A. Grebennikova (Volgograd, RU)
Thumbnail

Perceptions of heart failure treatment decision-making and side effects of heart failure treatment by patients and cardiologists: a multinational survey in the real-world cardiology setting

Speaker: Doctor S. Bruce Wirta (Stockholm, SE)
Thumbnail

CANCELLED - The effect of home-based cardiac rehabilitation following coronary artery bypass graft surgery in a low income country: A controlled trial

Speaker: Mr J. Uddin (Dhaka, BD)
Thumbnail

The optimal plasma volume status in heart failure in relation to clinical outcome

Speaker: Doctor P. Martens (Genk, BE)
Thumbnail

Empagliflozin improves renal outcomes in patients with or without heart failure at baseline - insights from the EMPA-REG OUTCOME trial

Speaker: Professor J. Butler (Jackson, US)
Thumbnail

The ketone body 3-hydroxybutyrate increases cardiac output and left ventricular contractile function in heart failure patients with reduced ejection fraction

Speaker: Doctor R. Nielsen (Aarhus, DK)
Thumbnail

Are target doses relevant for women with heart failure? - implications for sacubitril-valsartan

Speaker: Mrs H. Norberg (Umea, SE)
Thumbnail

Real-world titration and treatment patterns of sacubitril/valsartan in germany, a retrospective cohort study using a longitudinal pharmacy database

Speaker: Professor R. Wachter (Leipzig, DE)
Thumbnail

Persistence and compliance amongst sacubitril/valsartan patients in germany, a retrospective cohort study from a longitudinal pharmacy database

Speaker: Doctor S. Bruce Wirta (Stockholm, SE)
Thumbnail

14 speakers from this session

Doctor Joao AGOSTINHO

Hospital Universita­rio de Santa Maria/CHULN CAML CCUL Lisbon School of Medicine of the Universidade, Lisbon (Portugal)
0 follower

Doctor Anna Grebennikova

Volgograd State Medical University, Volgograd (Russian Federation)
0 follower

Doctor Sara Bruce Wirta

Novartis Sweden AB, Stockholm (Sweden)
0 follower

Mr Jamal Uddin

Ibrahim Cardiac Hospital & Research Institute, Dhaka (Bangladesh)
0 follower

Doctor Pieter Martens

Hospital Oost-Limburg (ZOL), Genk (Belgium)
1 presentation
0 follower

Professor Javed Butler

University of Mississippi, Jackson (United States of America)
65 presentations
3 followers

Doctor Roni Nielsen

Aarhus University Hospital, Aarhus (Denmark)
1 presentation
0 follower

Mrs Helena Norberg

Umea University, Umea (Sweden)
0 follower

Professor Rolf Wachter

Leipzig University Hospital, Leipzig (Germany)
7 presentations
0 follower

Doctor Sara Bruce Wirta

Novartis Sweden AB, Stockholm (Sweden)
0 follower

Doctor Verena Karsten

, Cambridge (United States of America)
0 follower

Doctor Rolf Wachter

Leipzig University Hospital, Leipzig (Germany)
7 presentations
0 follower

Assistant Professor Maja Cikes

University Hospital Centre Zagreb, Zagreb (Croatia)
23 presentations
1 follower

Mr Raed Odeh

King Abdulaziz Medical City, Riyadh (Saudi Arabia)
0 follower

This platform is supported by

logo Novo Nordisk